Clinical Trials in Latvia — Country Dashboard | 198 EU Studies

Filter these 198 trials by condition, phase, sponsor and more.

Open in Search →

198 Registered trials

56 Recruiting

126 Completed trials

95 Sponsors active

80 Research sites

Phase III

Phase II

Phase III: 131 Phase II/III: 14 Phase II: 41 Phase I/II: 1 Phase III/IV: 2 Phase IV: 4 Phase I: 2 Phase I (Other): 3

Oversight events in trials active here:

20 serious breaches 78 temporary halts 4 urgent safety measures 4 unexpected events 9 corrective measures across 31 trials

View oversight register →

Top conditions

Crohn's disease 7 Pulmonary arterial hypertension 6 Non-small cell lung cancer 6 Atrial fibrillation 4 Asthma 4 Neovascular age-related macular degeneration 4 Chronic obstructive pulmonary disease 3 Colitis ulcerative 3 Multiple sclerosis 2 Retinal vein occlusion 2 COVID-19 2 Cerebrovascular accident prophylaxis 2

Top sponsors

Merck Sharp & Dohme LLC 12 AbbVie Deutschland GmbH & Co. KG 10 Novartis Pharma AG 10 Amgen Inc. 8 Novo Nordisk A/S 7 Janssen - Cilag International 6 Takeda Development Center Americas Inc. 6 Argenx 4 Bayer AG 4 Boehringer Ingelheim Espana S.A. 4 Boehringer Ingelheim International GmbH 4 Eli Lilly & Co. 4

Cities with most trials

All 20 cities →

All trials — page 7

198 total

Clinical study to evaluate the handling and safety of AVT06 PFS in subjects with chorioretinal vascular disease (ALVOEYE-D). Ended

2023-505225-13-00 Phase III chorioretinal vascular disease (neovascular age-related macu… Alvotech Swiss AG
A study to investigate efficacy and safety of OG-6219 twice a day in 3 dose levels compared with Placebo in participants aged 18 to 49 with … Ended

2022-501310-57-00 Phase II Endometriosis related pain Organon LLC
Efficacy, safety, PK, PD, and immunogenicity of BP16 in post-menopausal osteoporosis Ended

2023-503790-37-00 Phase III Post-Menopausal Osteoporosis Curateq Biologics Private Limited
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Inhalation of Seralutinib for the … Ended

2023-503614-80-00 Phase III Pulmonary Arterial Hypertension GB002 Inc.
Extension Study to Assess Batoclimab in Participants with TED. Ended

2024-512650-21-00 Phase III Thyroid Eye Disease (TED) Immunovant Sciences GmbH
Efficacy and safety of Tanimilast in Asthmatics uNcontrolled on ICS-containinG backgrOund maintenance therapy Ended

2022-502208-64-00 Phase II Asthma Chiesi Farmaceutici S.p.A.
A large global trial to evaluate the efficacy and safety of milvexian in reducing recurrent cardiovascular events in patients after a heart … Ended

2022-501418-69-00 Phase III Acute Coronary Syndrome Janssen - Cilag International
A study in people with moderately to severely active ulcerative colitis to see how well an investigational treatment called PB016 works and … Ended

2022-502778-18-00 Phase III ulcerative colitis Polpharma Biologics S.A.
BP11 Versus EU-Approved Xolair® in Patients With Chronic Spontaneous Urticaria Ended

2024-514764-72-00 Phase III Chronic Urticaria Curateq Biologics Private Limited
A Ph3 Study to Evaluate the Efficacy and Safety of Pegozafermin in Subjects with Severe Hypertriglyceridemia: The ENTRUST study Ended

2023-503576-25-00 Phase III Severe Hypertriglyceridemia 89bio Inc.
A Multi-national Phase IIIb Trial to Determine the Safety and Efficacy of STALORAL® Birch 300 IR in Children and Adolescents 5 to 17 Years o… Ended

2023-509833-38-00 Phase III Birch Pollen-induced Allergic Rhinoconjunctivitis Stallergenes
A study to learn how well a higher amount of aflibercept given as an injection into the eye works and how safe it is in people with reduced … Ended

2022-502174-16-00 Phase III Macular edema secondary to retinal vein occlusion Bayer AG
Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE2) Ended

2022-502000-73-00 Phase III Focal Onset Seizures Xenon Pharmaceuticals Inc.
A study on the immune response and safety of a combined measles, mumps, rubella, chickenpox vaccine compared to a marketed combined vaccine,… Ended

2022-501564-18-00 Phase II Healthy volunteers (prevention of measles, mumps, rubella an… GlaxoSmithKline Biologicals
A Study to Evaluate the Efficacy and Safety of Astegolimab in Patients with Chronic Obstructive Pulmonary Disease Ended

2022-502234-70-00 Phase III Chronic Obstructive Pulmonary Disease (COPD) F. Hoffmann-La Roche AG
Long-term Safety and Efficacy of Efavaleukin Alfa in Subjects With Moderately to Severely Active Ulcerative Colitis Ended

2023-506046-24-00 Phase II Ulcerative Colitis (UC) Amgen Inc.
A trial to learn how well REGN9933 works for preventing blood clots after knee replacement surgery in adult participants Ended

2022-501470-18-00 Phase II Thromboembolic disease Regeneron Pharmaceuticals Inc.
Study to Assess the Efficacy and Safety of Cefepime/Nacubactam and Aztreonam/Nacubactam Versus Best Available Therapy in Adults With Complic… Ended

2024-515180-56-00 Phase III Complicated urinary tract infection (cUTI), acute uncomplica… Meiji Seika Pharma Co. Ltd.
Phase 3 Study to Assess Batoclimab in Participants with Active Thyroid Eye Disease Ended

2024-512649-18-00 Phase III Thyroid Eye Disease Immunovant Sciences GmbH
Study to Assess the Efficacy and Safety of Cefepime/Nacubactam or Aztreonam/Nacubactam Compared to Imipenem/Cilastatin in the Treatment of C… Ended

2024-515463-55-00 Phase III Complicated urinary tract infection (cUTI) and acute uncompl… Meiji Seika Pharma Co. Ltd.
Inhaled Imatinib Pulmonary Arterial Hypertension Clinical Trial – Follow Up Long Term Extension (IMPAHCT-FUL) Ended

2023-508735-31-00 Phase III Pulmonary Arterial Hypertension (PAH) Aerovate Therapeutics Inc.
A Multicenter, Open-Label, Evaluator-Blinded, Randomized Study to Evaluate the Safety and Tolerability of Single-Dose IV Oritavancin for the… Ended

2024-516385-10-00 Phase II Acute Bacterial Skin and Skin Structure Infections Melinta Therapeutics LLC
A Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab Monotherapy in Moderate-to-severe AD (ROCKET-Ignite) Ended

2022-501540-15-00 Phase III Atopic Dermatitis Amgen Inc.
A study to evaluate the efficacy and safety of Bemnifosbuvir in High-Risk Outpatients with COVID-19 Ended

2023-504540-33-00 Phase III COVID-19 Atea Pharmaceuticals Inc.

Showing 145–168 of 198 trials

← All countries